STOCK TITAN

Codexis (NASDAQ: CDXS) reports Q2 2025 results via earnings release

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Codexis, Inc. filed a current report to disclose that it has announced its financial results for the quarter ended June 30, 2025. The company released these results through a press release dated August 13, 2025, which is furnished as Exhibit 99.1. This press release contains the detailed quarterly financial information. The exhibit is furnished rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other securities offerings unless specifically referenced.

Positive

  • None.

Negative

  • None.
false 0001200375 0001200375 2025-08-13 2025-08-13
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 13, 2025

 

 

Codexis, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34705   71-0872999

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

200 Penobscot Drive

Redwood City, CA 94063

(Address of Principal Executive Offices) (Zip Code)

(650) 421-8100

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading

Symbols(s)

 

Name of Each Exchange

on Which Registered

Common Stock, par value $0.0001 per share   CDXS   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02

Results of Operations and Financial Condition.

On August 13, 2025, Codexis, Inc. announced its financial results for the quarter ended June 30, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

 

Item 9.01

Financial Statements and Exhibits.

 

Exhibit No.    Description
99.1    Press release dated August 13, 2025 relating to the financial results for the quarter ended June 30, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CODEXIS, INC.
Date: August 13, 2025     By:  

/s/ Georgia Erbez

      Georgia Erbez
      Chief Financial Officer

FAQ

What did Codexis (CDXS) disclose in this 8-K filing?

Codexis disclosed that it announced its financial results for the quarter ended June 30, 2025, and provided the full details in a press release furnished as Exhibit 99.1.

Which period do the Codexis (CDXS) results in this filing cover?

The results relate to Codexis’s financial performance for the quarter ended June 30, 2025.

How did Codexis (CDXS) make its Q2 2025 results available?

Codexis made its Q2 2025 results available through a press release dated August 13, 2025, which is furnished as Exhibit 99.1 to the report.

Is the Codexis (CDXS) earnings press release considered filed with the SEC?

The company states that the information in Item 2.02, including Exhibit 99.1, is furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act.

Who signed this Codexis (CDXS) 8-K related to Q2 2025 results?

The report was signed on behalf of Codexis, Inc. by Georgia Erbez, the company’s Chief Financial Officer.

What exhibits are included with this Codexis (CDXS) 8-K filing?

The filing includes Exhibit 99.1, the press release detailing financial results for the quarter ended June 30, 2025, and Exhibit 104, the cover page interactive data file.
Codexis Inc

NASDAQ:CDXS

View CDXS Stock Overview

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

146.30M
83.75M
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY